- Lopinavir/ritonavir (LPV/r), sold
under the
brand name
Kaletra among others, is a fixed-dose
combination antiretroviral medication for the
treatment and...
-
government announced that it
would force AbbVie to
license its
patents for
Kaletra, the
brand name of lopinavir/ritonavir, a
fixed dose
combination medication...
- 6972–6993. doi:10.1002/anie.201410356. PMC 4479028. PMID 26031248. "
Kaletra FAQ". AbbVie's
Kaletra product information. AbbVie. 2011.
Archived from the original...
- Niaspan);
Specific HIV
protease inhibitors such as:
lopinavir and
ritonavir (
Kaletra), and
ritonavir (Norvir)
taken with
darunavir (Prezista); and spironolactone...
-
trial aiming at
monthly dosing (NCT05850728). "FDA
Approved Drug Products:
Kaletra".
Retrieved 30
April 2004.
Fischer J,
Ganellin CR (2006). Analogue-based...
-
December 31, 2004, as it has been su****ded by fosamprenavir.
Lopinavir Kaletra AbbVie U.S.
patent 5,914,332
September 15, 2000 Is only
marketed as a fixed-dose...
-
Kafocin Kainair kainic acid (INN)
Kaitlib Fe
kalafungin (INN)
Kalbitor Kaletra Kalexate kallidinogenase (INN)
Kalliga Kalydeco kanamycin (INN) Kanjinti...
-
drugs being administered to COVID-19
patients in
clinical trials in China:
Kaletra,
Chloroquine phosphate, and Hydroxychloroquine. BBC
Radio 1
cancels its...
- a "national emergency."
Breaking the
patents of Abbott's HIV
treatment Kaletra and Sanofi-Aventis'
blood clot drug
Plavix was
estimated to save Thailand...
- Wikipedia. "LPV/r"
refers to the HIV drug Lopinavir/Ritonavir (trade names:
Kaletra / Aluvia) Blue
Origin Landing Platform Vessel 1 (LPV-1), a
landing platform...
